Intrexon   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Blacksburg VA United States (1998)

Organization Overview

First Clinical Trial
2011
NCT00968760
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Intrexon Corporation | Intrexon T1D Partners, LLC | Precigen, Inc | Xogenex, LLC